Shareholding disclosure

Basilea Pharmaceutica AG, Allschwil

Collectively declared rate

3%

Threshold

Fell below threshold

Timeline

Published

03.04.2008

Transaction

20.03.2008

Transfer date

20.03.2008

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T5993D5750

Beneficial owner

Deutsche Asset Management Investmentgesellschaft mbH

Declared address

Deutsche Asset Management Investmentgesellschaft mbH, Frankfurt am Main

Deutsche Bank AG, Frankfurt, Zweigniederlassung Zürich, Uraniastrasse 9, 8001 Zürich, meldete am 27. März 2008 an die Basilea Pharmaceutica AG, dass die Beteiligung an der Basilea Pharmaceutica AG von der Deutschen Bank AG, Frankfurt, Theodor-Heuss-Allee 70, 60486 Frankfurt, Deutschland, und der Deutschen Asset Management Investmentgesellschaft mbH, Mainzer Landstrasse 178-190, 60327 Frankfurt, Deutschland, die beide zum gleichen Konzern gehören, am 20. März 2008 infolge Veräusserung unter die meldepflichtigen Schwellenwerte gefallen ist.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open